Cut-off points for CypA >8.2 ng/mL and C > 17.5 pg/mL were obtained from ROC curves of our preliminary study and validated in the present study in CAD patients with or without cardiovascular risk factors associated (Alfonso et al., 2019). This evidence concerns the gene PPIA and coronary artery disorder.